Alkylating drugs applied in non-cytotoxic doses as a novel compounds targeting inflammatory signal pathway

Biochemical Pharmacology
A PukhalskyA Sabelnikov

Abstract

Alkylating drugs (ADs) belonging to the nitrogen mustard family are commonly used as cytostatic and immunosuppressive agents. Our previous in vitro studies demonstrated that in the case of gradual dose decrease, the number of targets for alkylation in the cell is also reduced and the drug switches from brutal cytostatic to cell growth modifier. At doses of 0.3 microg/ml and lower, the effects of ADs are no longer associated with DNA damage or stress/MAPK pathways activation. Instead, the disruption of signal transduction by the IL-2beta and/or TNFalpha cell surface receptors is observed. As a result, ADs in the doses 100-fold lower than cytostatic ones are capable to modify lymphocyte activity including the activity of regulatory T cells. We hypothesized that ADs may have a beneficial effect in the treatment of inflammatory diseases. Indeed, the application of non-cytotoxic doses of an AD melphalan reduces the severity of murine experimental colitis. Daily administration of melphalan (25 microg/kg body weight) markedly reduced the severity of DSS-colitis as determined by clinical and histological criteria. Moreover, the beneficial effect of melphalan was also shown in asthmatic patients. In 60% of these patients histological an...Continue Reading

References

Jan 1, 1990·Cancer Immunology, Immunotherapy : CII·S K HooverH D Bear
Oct 1, 1989·Seminars in Oncology·D C DollJ W Yarbro
Jan 7, 1999·The European Respiratory Journal·M KolbM Schmidt
Jun 22, 2000·International Journal of Cancer. Journal International Du Cancer·M P VierboomC J Melief
Jan 11, 2003·Science·Shohei HoriShimon Sakaguchi
Mar 4, 2003·Nature Immunology·Jason D FontenotAlexander Y Rudensky
Sep 3, 2004·Nature Reviews. Immunology·Thomas R Malek, Allison L Bayer
Jan 1, 1995·Mediators of Inflammation·A PukhalskyS Khaidukov

❮ Previous
Next ❯

Citations

Sep 24, 2013·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Cristina Maria de SouzaGeovanni Dantas Cassali

❮ Previous
Next ❯

Related Concepts

Related Feeds

Asthma

This feed focuses in Asthma in which your airways narrow and swell. This can make breathing difficult and trigger coughing, wheezing and shortness of breath.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.